Search Results

Filter
  • 1-10 of  1,828 results for ""Angiotensin II Type 1 Receptor Blockers""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A Bioequivalence Study of Azilsartan in Healthy Chinese Subjects.

  • Authors : Liu X; Anqing Medical College, Anqing, China.; Dai X

Subjects: Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/pharmacokinetics ; Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/administration & dosage ; Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/adverse effects

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Dec; Vol. 13 (12), pp. 1301-1307. Date of Electronic Publication: 2024 Oct 18.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Achieved dose and treatment discontinuation of candesartan in men and women with chronic heart failure: data from CHARM.

  • Authors : Qin H; Department of Cardiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.; Dewan P

Subjects: Biphenyl Compounds* ; Tetrazoles*/Tetrazoles*/Tetrazoles*/administration & dosage ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

  • Source: ESC heart failure [ESC Heart Fail] 2024 Aug; Vol. 11 (4), pp. 1880-1887. Date of Electronic Publication: 2024 Apr 05.Publisher: John Wiley & Sons Ltd on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 101669191 Publication Model:

Record details

×
Academic Journal

Candesartan restores blood-brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis.

  • Authors : Hammer MF; BIO5 Institute, University of Arizona, Tucson, AZ, U.S.A.; Department of Neurology, University of Arizona, Tucson, AZ, U.S.A.

Subjects: Biphenyl Compounds*/Biphenyl Compounds*/Biphenyl Compounds*/pharmacology ; Biphenyl Compounds*/Biphenyl Compounds*/Biphenyl Compounds*/therapeutic use ; Blood-Brain Barrier*/Blood-Brain Barrier*/Blood-Brain Barrier*/metabolism

  • Source: Clinical science (London, England : 1979) [Clin Sci (Lond)] 2024 Sep 04; Vol. 138 (17), pp. 1089-1110.Publisher: Portland Press on behalf of the Medical Research Society and the Biochemical Society Country of Publication: England NLM ID: 7905731 Publication Model:

Record details

×
Academic Journal

Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications.

  • Authors : Basmadjian OM; Instituto de Farmacología Experimental de Córdoba (IFEC-CONICET), Departamento de Farmacología Otto Orsingher, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.; Occhieppo VB

Subjects: Amphetamine*/Amphetamine*/Amphetamine*/pharmacology ; Dopamine*/Dopamine*/Dopamine*/metabolism ; Corpus Striatum*/Corpus Striatum*/Corpus Striatum*/drug effects

  • Source: The European journal of neuroscience [Eur J Neurosci] 2024 May; Vol. 59 (10), pp. 2450-2464. Date of Electronic Publication: 2024 Mar 13.Publisher: Wiley-Blackwell Country of Publication: France NLM ID: 8918110 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

An immunochromatographic strip sensor for rapid and sensitive detection of candesartan, olmesartan medoxomil, and irbesartan in herbal beverages.

  • Authors : Li D; State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China. .; International Joint Research Laboratory for Biointerface and Biodetection, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China.

Subjects: Angiotensin II Type 1 Receptor Blockers* ; Beverages* ; Benzimidazoles*

  • Source: Analytical methods : advancing methods and applications [Anal Methods] 2024 Apr 18; Vol. 16 (15), pp. 2359-2367. Date of Electronic Publication: 2024 Apr 18.Publisher: RSC Pub Country of Publication: England NLM ID: 101519733 Publication Model: Electronic Cited Medium: Internet ISSN: 1759-9679

Record details

×
Academic Journal

Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure.

  • Authors : Kassem I; Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.; Montreal Heart Institute, Montreal, Quebec, Canada.

Subjects: Models, Biological*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacokinetics ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*pharmacokinetics

  • Source: Clinical and translational science [Clin Transl Sci] 2021 Jan; Vol. 14 (1), pp. 194-203. Date of Electronic Publication: 2020 Aug 28.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover Trial.

  • Authors : Suehiro T; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Department of Nephrology, Harasanshin Hospital, Fukuoka, Japan.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

  • Source: Kidney & blood pressure research [Kidney Blood Press Res] 2021; Vol. 46 (2), pp. 173-184. Date of Electronic Publication: 2021 Mar 05.Publisher: Karger Country of Publication: Switzerland NLM ID: 9610505 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0143

Record details

×
Academic Journal

Design and optimization of candesartan loaded self-nanoemulsifying drug delivery system for improving its dissolution rate and pharmacodynamic potential.

  • Authors : Verma R; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India.; Kaushik D

Subjects: Drug Design*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*administration & dosage ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*administration & dosage

  • Source: Drug delivery [Drug Deliv] 2020 Dec; Vol. 27 (1), pp. 756-771.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464

Record details

×
Academic Journal

Design, synthesis and biological evaluation of AT 1 receptor blockers derived from 6-substituted aminocarbonyl benzimidazoles.

  • Authors : Wu Z; Department of Pharmaceutical Science and Technology, College of Chemistry and Biology, Donghua University, Shanghai, 201620, China.; Anh NTP

Subjects: Drug Design*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*pharmacology

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2019 Nov 01; Vol. 181, pp. 111553. Date of Electronic Publication: 2019 Jul 24.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2019 Aug; Vol. 28 (8), pp. 2262-2267. Date of ElectronicPublisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  1,828 results for ""Angiotensin II Type 1 Receptor Blockers""